You are here

Stage IV NSCLC and New Targets: RET

Post ASCO 2019 Lung Cancer Round Table Discussion - Stage IV NSCLC and New Targets: RET

H. Jack West, MD, Founder, President and CEO

We are excited to share with you more videos from a recent series of discussions between Drs. Howard (Jack) West, MD, Associate Clinical Professor, Medical Oncology, Executive Director, Employer Services at City of Hope Comprehensive Cancer Center, and Founder, President and CEO Of GRACE, Charu Aggarwal, MD, MPH with the Perelman Center for Advanced Medicine, University of Pennsylvania, and Benjamin Levy MD, Clinical Director Of Medical Oncology, Assistant Professor Of Oncology at the Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital.

The doctors recently collaborated from their respective geographical locations to review top discussion points from Lung Cancer from ASCO 2019. In this video, the doctors discuss stage 4 non-small cell lung cancer and new targets, specifically RET.

Please visit our community forums with any questions or comments!

Video Language:

English

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

Join The conversation

form.antibot { display: none !important; } You must have JavaScript enabled to use this form.

Related Content

Supportive Care - Chemotherapy-Induced Peripheral Neuropathy (CIPN)

Video

We are very excited to bring to you this new program on supportive care in cancer treatment. Arjun Gupta, MD, one of the GRACE Fellows Ambassador Program Winners for 2019 is the host of this video series, Supportive Care in Cancer Treatment. In this first video, Dr. Gupta's guest is Charles Loprinzi, MD, with the Mayo Clinic in Rochester, MN. Their topic of discussion is Chemotherapy-induced peripheral neuropathy (CIPN).